Sergey Nejentsev
Professor Sergey Nejentsev is a leading researcher at the University of Cambridge who was instrumental in identifying the genetic cause of Activated PI3-kinase Delta Syndrome (APDS). He expressed excitement over the recent approval of leniolisib, a drug that targets the condition, marking a significant step forward in treatment options for affected patients.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Prof Sergey Nejentsev from the University of Cambridge who led the research that discovered APDS said: 'As soon as we understood the cause of APDS, we immediately realised that certain drugs could be used to inhibit the enzyme that is activated in these patients.'
9